Close Menu

hepatitis

The studies will test Arrowhead's drug in combination with one of two direct-acting antiviral therapies.

The new claims allow for pre-transplantation testing of organ and tissue donations for HIV, hepatitis B virus, hepatitis C virus, and West Nile virus.

Roche today said that its Cobas HIV-1 and HCV next-generation viral load monitoring assays have received CE marking. 

Officials said the firm remains confident in its HBV drug despite investors' negative reaction to Phase IIa data.

 

The company also announced deals for new DNA production and delivery technologies.

NEW YORK (GenomeWeb) – As Phase I testing of its hemophilia therapy ALN-AT3 continues, Alnylam Pharmaceuticals is setting its sights broadly for the program, taking aim at both patients receiving standard medical care as well as those who have become refractory to such treatment, company official

NEW YORK (GenomeWeb) – Just days after presenting Phase II data on its lead hepatitis B drug candidate that failed to meet Wall Street expectations and sent its stock into a tailspin, Arrowhead Research has been sued in two class action lawsuits alleging that the company misled investors as to wh

NEW YORK (GenomeWeb) – Shares of Arrowhead Research tumbled this week after the release of data from an ongoing Phase IIa trial of its siRNA-based hepatitis B drug ARC-520 showed unexpectedly modest reductions in HBV surface antigen (s-antigen), a key indicator of active infection.

NEW YORK (GenomeWeb) — Roche said today that it has received CE marking for the cobas 6800/8800 automated molecular testing systems for blood and plasma donor screening.

NEW YORK (GenomeWeb) – Mayo Medical Laboratories will collaborate with Advanced Biological Laboratories to develop a next-generation sequencing pipeline for laboratory-developed diagnostic tests.

Pages

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.